204 related articles for article (PubMed ID: 22546513)
1. Interaction among apoptosis-associated sequence variants and joint effects on aggressive prostate cancer.
Lavender NA; Rogers EN; Yeyeodu S; Rudd J; Hu T; Zhang J; Brock GN; Kimbro KS; Moore JH; Hein DW; Kidd LC
BMC Med Genomics; 2012 Apr; 5():11. PubMed ID: 22546513
[TBL] [Abstract][Full Text] [Related]
2. Interaction among variant vascular endothelial growth factor (VEGF) and its receptor in relation to prostate cancer risk.
VanCleave TT; Moore JH; Benford ML; Brock GN; Kalbfleisch T; Baumgartner RN; Lillard JW; Kittles RA; Kidd LC
Prostate; 2010 Mar; 70(4):341-52. PubMed ID: 19908237
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor-associated sequence variants and prostate cancer risk among men of African descent.
Rogers EN; Jones DZ; Kidd NC; Yeyeodu S; Brock G; Ragin C; Jackson M; McFarlane-Anderson N; Tulloch-Reid M; Sean Kimbro K; Kidd LR
Genes Immun; 2013 Sep; 14(6):347-55. PubMed ID: 23657238
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants in cell cycle control pathway confer susceptibility to aggressive prostate carcinoma.
Kibel AS; Ahn J; Isikbay M; Klim A; Wu WS; Hayes RB; Isaacs WB; Daw EW
Prostate; 2016 Apr; 76(5):479-90. PubMed ID: 26708993
[TBL] [Abstract][Full Text] [Related]
5. No association between variant DNA repair genes and prostate cancer risk among men of African descent.
Lavender NA; Komolafe OO; Benford M; Brock G; Moore JH; Vancleave TT; States JC; Kittles RA; Kidd LC
Prostate; 2010 Feb; 70(2):113-9. PubMed ID: 19760636
[TBL] [Abstract][Full Text] [Related]
6. Prostate genetic score (PGS-33) is independently associated with risk of prostate cancer in the PLCO trial.
Liss MA; Xu J; Chen H; Kader AK
Prostate; 2015 Sep; 75(12):1322-8. PubMed ID: 25982801
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide two-locus epistasis scans in prostate cancer using two European populations.
Tao S; Feng J; Webster T; Jin G; Hsu FC; Chen SH; Kim ST; Wang Z; Zhang Z; Zheng SL; Isaacs WB; Xu J; Sun J
Hum Genet; 2012 Jul; 131(7):1225-34. PubMed ID: 22367438
[TBL] [Abstract][Full Text] [Related]
8. Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer.
Briollais L; Ozcelik H; Xu J; Kwiatkowski M; Lalonde E; Sendorek DH; Fleshner NE; Recker F; Kuk C; Olkhov-Mitsel E; Savas S; Hanna S; Juvet T; Hunter GA; Friedlander M; Li H; Chadwick K; Prassas I; Soosaipillai A; Randazzo M; Trachtenberg J; Toi A; Shiah YJ; Fraser M; van der Kwast T; Bristow RG; Bapat B; Diamandis EP; Boutros PC; Zlotta AR
J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 28376164
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants in the cholesterol biosynthesis pathway genes and risk of prostate cancer.
Cheng Y; Meng Y; Li S; Cao D; Ben S; Qin C; Hua L; Cheng G
Gene; 2021 Mar; 774():145432. PubMed ID: 33444688
[TBL] [Abstract][Full Text] [Related]
10. Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.
Xu J; Zheng SL; Isaacs SD; Wiley KE; Wiklund F; Sun J; Kader AK; Li G; Purcell LD; Kim ST; Hsu FC; Stattin P; Hugosson J; Adolfsson J; Walsh PC; Trent JM; Duggan D; Carpten J; Grönberg H; Isaacs WB
Proc Natl Acad Sci U S A; 2010 Feb; 107(5):2136-40. PubMed ID: 20080650
[TBL] [Abstract][Full Text] [Related]
11. Variation in selenoenzyme genes and prostate cancer risk and survival.
Geybels MS; Hutter CM; Kwon EM; Ostrander EA; Fu R; Feng Z; Stanford JL; Peters U
Prostate; 2013 May; 73(7):734-42. PubMed ID: 23143801
[TBL] [Abstract][Full Text] [Related]
12. Interactions among genetic variants in apoptosis pathway genes, reflux symptoms, body mass index, and smoking indicate two distinct etiologic patterns of esophageal adenocarcinoma.
Zhai R; Chen F; Liu G; Su L; Kulke MH; Asomaning K; Lin X; Heist RS; Nishioka NS; Sheu CC; Wain JC; Christiani DC
J Clin Oncol; 2010 May; 28(14):2445-51. PubMed ID: 20385987
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants in RNA-induced silencing complex genes and prostate cancer.
Nikolić Z; Savić Pavićević D; Vučić N; Cerović S; Vukotić V; Brajušković G
World J Urol; 2017 Apr; 35(4):613-624. PubMed ID: 27498138
[TBL] [Abstract][Full Text] [Related]
14. Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases.
Helfand BT; Roehl KA; Cooper PR; McGuire BB; Fitzgerald LM; Cancel-Tassin G; Cornu JN; Bauer S; Van Blarigan EL; Chen X; Duggan D; Ostrander EA; Gwo-Shu M; Zhang ZF; Chang SC; Jeong S; Fontham ET; Smith G; Mohler JL; Berndt SI; McDonnell SK; Kittles R; Rybicki BA; Freedman M; Kantoff PW; Pomerantz M; Breyer JP; Smith JR; Rebbeck TR; Mercola D; Isaacs WB; Wiklund F; Cussenot O; Thibodeau SN; Schaid DJ; Cannon-Albright L; Cooney KA; Chanock SJ; Stanford JL; Chan JM; Witte J; Xu J; Bensen JT; Taylor JA; Catalona WJ
Hum Genet; 2015 Apr; 134(4):439-50. PubMed ID: 25715684
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in oxidative stress pathway genes and prostate cancer risk.
Zhang Z; Jiang D; Wang C; Garzotto M; Kopp R; Wilmot B; Thuillier P; Dang A; Palma A; Farris PE; Shannon J
Cancer Causes Control; 2019 Dec; 30(12):1365-1375. PubMed ID: 31667711
[TBL] [Abstract][Full Text] [Related]
16. Association of variants in estrogen-related pathway genes with prostate cancer risk.
Holt SK; Kwon EM; Fu R; Kolb S; Feng Z; Ostrander EA; Stanford JL
Prostate; 2013 Jan; 73(1):1-10. PubMed ID: 22549291
[TBL] [Abstract][Full Text] [Related]
17. 8q24 sequence variants in relation to prostate cancer risk among men of African descent: a case-control study.
Benford ML; VanCleave TT; Lavender NA; Kittles RA; Kidd LR
BMC Cancer; 2010 Jun; 10():334. PubMed ID: 20584312
[TBL] [Abstract][Full Text] [Related]
18. A Multiple Interaction Analysis Reveals ADRB3 as a Potential Candidate for Gallbladder Cancer Predisposition via a Complex Interaction with Other Candidate Gene Variations.
Rai R; Kim JJ; Misra S; Kumar A; Mittal B
Int J Mol Sci; 2015 Nov; 16(12):28038-49. PubMed ID: 26602921
[TBL] [Abstract][Full Text] [Related]
19. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
20. KLK3 SNP-SNP interactions for prediction of prostate cancer aggressiveness.
Lin HY; Huang PY; Cheng CH; Tung HY; Fang Z; Berglund AE; Chen A; French-Kwawu J; Harris D; Pow-Sang J; Yamoah K; Cleveland JL; Awasthi S; Rounbehler RJ; Gerke T; Dhillon J; Eeles R; Kote-Jarai Z; Muir K; ; Schleutker J; Pashayan N; ; Neal DE; Nielsen SF; Nordestgaard BG; Gronberg H; Wiklund F; Giles GG; Haiman CA; Travis RC; Stanford JL; Kibel AS; Cybulski C; Khaw KT; Maier C; Thibodeau SN; Teixeira MR; Cannon-Albright L; Brenner H; Kaneva R; Pandha H; ; Srinivasan S; Clements J; Batra J; Park JY
Sci Rep; 2021 Apr; 11(1):9264. PubMed ID: 33927218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
